| ORIGINAL ARTICLE |
|
| Year : 2014 | Volume
: 9
| Issue : 3 | Page : 126-129 |
|
|
Prevalence of adenocarcinoma among cervical cancer patients in Igbos of Nigeria
KO Ngwogu1, AC Ngwogu2, GIN Ndubuka3
1 Department of Chemical Pathology, Faculty of Clinical Medicine, College of Medicine and Health Sciences, Abia State University, Uturu, Abia State, Nigeria
2 Department of Medical Microbiology, Faculty of Clinical Medicine, College of Medicine and Health Sciences, Abia State University, Uturu, Abia State, Nigeria
3 Department of Biomedical Technology, Federal University of Technology, Owerri, Ihiagwa, Nigeria
Correspondence Address:
K O Ngwogu
Faculty of Clinical Medicine, College of Medicine and Health Sciences, Abia State University, Uturu, Abia State
Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/9783-1230.144775
|
|
|
Background: Adenocarcinoma of the cervix, although a common problem among females in Nigeria is often poorly screened and consequently under-detected. There is a need for improved awareness and early screening to stem the trend of increasing mortality. Objective: To determine the prevalence of adenocarcinoma among cervical cancer patients in Igbos of Nigeria. Design: Data sources from surgical specimens from 40 hospitals spread across the five states of South Eastern Nigeria. Setting: National Orthopedic Hospital, Enugu, in South Eastern Nigeria. Materials and Methods: A total of 206 cervical histopathology reports obtained from patients of the Igbo ethnic group of Nigeria between January 2007 and December 2010 were selected and studied. Results: Prevalence of adenocarcinoma is 11.5% with a mean age of presentation at 62 ± 6.4 years. It is associated with irregular vaginal bleeding (60%), vaginal discharge (15%), lower abdominal pains (13%), and post-coital bleeding (12%). Age and parity of the patients appeared to be significantly associated with the prevalence of the disease. Conclusion: There is a need for increased awareness and periodic screening to ensure early detection and institution of therapy. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
